TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
VSTM

Verastem Inc

Healthcare · Biotechnology

8.40$ +3.3% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Verastem Inc (VSTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 207 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VSTM
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
89 84 76 62 63 90 68 173 183 277 243 219 193 145 208 199 218 154 137 124 112 109 116 100 111 95 121 192 176 150 124 106 126 102 132 196 177 246 228 207
87 81 74 60 61 88 66 170 159 253 217 192 167 85 149 145 189 145 128 115 109 106 113 98 109 93 119 190 174 144 118 100 121 95 125 174 154 223 203 176
37 32 28 28 51 82 64 169 131 130 92 113 103 44 135 125 170 68 36 25 24 21 47 64 78 75 97 183 95 78 81 83 113 89 118 164 138 205 166 136
87 81 73 58 60 87 64 169 146 250 212 187 160 76 135 125 170 141 121 108 103 100 106 94 104 88 111 183 166 137 110 83 113 89 118 164 138 214 182 136
– 0.2 0.2 – – – – – 11 0.3 0.6 1.4 2.2 2.5 3.3 1.5 5.7 0.2 1.1 0.5 0.1 0.5 2.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 11 0.2 0.2 0.2 2.3 6.7 0.2 10 29
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.5 3.1 4.4 6.3 9.4 0.0 – – – -101 – – – – -0.1 – 0.0 – – – – 0.0 – 1.2 1.8 1.8 2.3 2.4
1.6 1.4 1.3 1.1 1.0 0.9 1.0 1.3 1.2 1.4 1.3 4.4 1.0 0.9 0.9 0.8 0.5 3.1 0.3 2.8 0.2 0.2 0.2 2.2 0.1 0.1 0.1 0.0 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22 22 21 21 20 20 20 19 – – – – – – – – – – – – – – – – – – – 16 17 16 16 16
6.6 11 16 14 22 32 30 46 76 153 155 169 171 138 85 84 88 39 34 36 16 21 43 47 48 48 67 69 72 92 77 66 94 130 164 160 192 189 146 157
6.2 11 13 11 20 17 15 22 53 37 29 31 31 30 26 29 38 17 12 13 14 19 17 20 22 22 22 21 24 26 27 30 37 31 36 50 60 72 67 78
– – 2.2 2.3 2.3 15 15 1.4 3.5 5.7 0.2 0.3 0.4 0.4 0.5 5.1 9.8 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 1.1 2.1 1.7 1.3 0.9 1.9 6.5 11 1.0 3.0 4.2 5.1 5.8 6.3 6.4
2.0 4.1 8.8 6.8 7.4 9.2 7.3 8.5 11 10 8.6 12 8.8 9.7 7.2 2.2 4.7 1.9 2.5 1.4 0.6 2.3 2.9 1.7 5.4 4.9 4.9 4.6 5.1 7.2 7.4 6.7 4.4 4.0 7.2 8.0 9.9 12 9.6 18
0.0 0.0 2.2 2.3 2.3 15 15 24 22 115 122 134 136 104 55 51 47 19 20 20 0.2 0.2 24 25 25 25 40 40 40 40 40 35 31 41 73 81 84 81 77 76
82 72 60 48 41 58 39 127 108 124 88 49 22 7.2 123 114 130 115 103 88 96 88 73 54 63 47 54 123 104 57 46 40 32 -29 -32 36 -16 57 82 50
-224 -235 -248 -262 -285 -303 -324 -343 -364 -376 -414 -456 -486 -525 -563 -586 -573 -593 -608 -624 -647 -664 -681 -703 -721 -738 -753 -778 -798 -825 -859 -867 -891 -956 -1,008 -1,034 -1,132 -1,165 -1,202 -1,236
3.1 3.1 3.1 3.1 3.1 3.5 4.2 5.1 6.1 7.6 6.2 6.2 6.2 6.4 9.0 14 14 14 14 14 15 15 16 16 16 17 17 18 27 27 27 27 40 38 54 74 73 83 99 100

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?